Total Payments
$1,087
2024 Payments
$326.83
Companies
9
Transactions
58
Medicare Patients
433
Medicare Billing
$45,225
Payment Breakdown by Category
Food & Beverage$1,087 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,087 | 58 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $393.45 | 25 | $0 (2024) |
| GlaxoSmithKline, LLC. | $244.37 | 12 | $0 (2024) |
| Exact Sciences Corporation | $203.10 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $75.81 | 5 | $0 (2024) |
| Lilly USA, LLC | $75.30 | 3 | $0 (2024) |
| ABBVIE INC. | $33.62 | 1 | $0 (2023) |
| PFIZER INC. | $30.64 | 2 | $0 (2023) |
| Amgen Inc. | $17.12 | 1 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $13.32 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $326.83 | 17 | Exact Sciences Corporation ($103.31) |
| 2023 | $593.80 | 34 | Novo Nordisk Inc ($296.50) |
| 2022 | $29.84 | 2 | Novo Nordisk Inc ($29.84) |
| 2021 | $136.26 | 5 | GlaxoSmithKline, LLC. ($136.26) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $29.50 | General |
| Category: Oncology | ||||||
| 08/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Obesity | ||||||
| 07/24/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Oncology | ||||||
| 07/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Diabetes | ||||||
| 05/21/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Oncology | ||||||
| 05/14/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: Obesity | ||||||
| 05/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Diabetes | ||||||
| 05/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Respiratory | ||||||
| 04/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: RESPIRATORY | ||||||
| 03/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Respiratory | ||||||
| 02/15/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $30.52 | General |
| Category: Oncology | ||||||
| 02/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: RESPIRATORY | ||||||
| 01/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Inflammation | ||||||
| 12/07/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $10.03 | General |
| 11/16/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Diabetes | ||||||
| 11/15/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Obesity | ||||||
| 10/11/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Diabetes | ||||||
| 10/04/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $31.09 | General |
| Category: Oncology | ||||||
| 10/03/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: Diabetes | ||||||
| 09/11/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 69 | 116 | $14,990 | $9,073 |
| 2022 | 2 | 86 | 169 | $21,060 | $12,344 |
| 2021 | 5 | 101 | 246 | $17,743 | $11,103 |
| 2020 | 8 | 177 | 318 | $24,380 | $12,705 |
Total Patients
433
Total Services
849
Medicare Billing
$45,225
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 69 | $10,350 | $6,118 | 59.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 47 | $4,640 | $2,955 | 63.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 91 | $13,650 | $7,891 | 57.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 43 | 78 | $7,410 | $4,453 | 60.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 61 | $9,150 | $5,809 | 63.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 68 | $6,460 | $4,490 | 69.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 17 | 22 | $1,540 | $750.71 | 48.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 11 | 51 | $153.00 | $38.36 | 25.1% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2021 | 12 | 44 | $440.00 | $14.85 | 3.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 39 | 83 | $11,245 | $5,289 | 47.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 42 | 79 | $6,885 | $3,963 | 57.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 16 | 20 | $1,420 | $1,075 | 75.7% |
| 90682 | Vaccine for influenza for injection into muscle | Office | 2020 | 16 | 16 | $960.00 | $960.00 | 100.0% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 17 | 24 | $1,590 | $859.92 | 54.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 18 | 27 | $1,350 | $275.46 | 20.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 16 | 16 | $400.00 | $260.32 | 65.1% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2020 | 13 | 53 | $530.00 | $23.76 | 4.5% |
About Dean Mast
Dean Mast is a Emergency Medicine healthcare provider based in Olean, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1760525406.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dean Mast has received a total of $1,087 in payments from pharmaceutical and medical device companies, with $326.83 received in 2024. These payments were reported across 58 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,087).
As a Medicare-enrolled provider, Mast has provided services to 433 Medicare beneficiaries, totaling 849 services with total Medicare billing of $45,225. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Location Olean, NY
- Active Since 02/14/2007
- Last Updated 01/25/2024
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1760525406
Products in Payments
- TRELEGY ELLIPTA (Drug) $244.37
- Cologuard Collection Kit (Device) $203.10
- Rybelsus (Drug) $169.03
- Ozempic (Drug) $148.78
- ZEPBOUND (Drug) $49.59
- Wegovy (Drug) $35.28
- VRAYLAR (Drug) $33.62
- FARXIGA (Drug) $31.87
- COMIRNATY (Biological) $30.64
- AIRSUPRA (Drug) $27.99
- MOUNJARO (Drug) $25.71
- Otezla (Drug) $17.12
- BREZTRI (Drug) $15.95
- TOUJEO (Biological) $13.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.